ES / EN
- July 5, 2025 -
No Result
View All Result
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
Home Cuba

Cuba inaugurates plant to produce drug against COVID-19

At the plant, located at Havana’s Center for Genetic Engineering and Biotechnology, the active pharmaceutical ingredient of the drug Jusvinza will be produced, successfully used in the treatment of seriously and critically ill patients with the disease caused by the SARS-CoV-2 coronavirus.

by
  • OnCuba Staff
    OnCuba Staff,
  • OnCuba editorial staff
July 31, 2020
in Cuba
0
Cuban President Miguel Díaz-Canel (c) inaugurates a synthetic peptides production plant at the Center for Genetic Engineering and Biotechnology (CIGB) in Havana, on July 30, 2020. Photo: Presidencia Cuba/Twitter.

Cuban President Miguel Díaz-Canel (c) inaugurates a synthetic peptides production plant at the Center for Genetic Engineering and Biotechnology (CIGB) in Havana, on July 30, 2020. Photo: Presidencia Cuba/Twitter.

Help us keep OnCuba alive

A synthetic peptides production plant, in which a drug used successfully in Cuba against COVID-19 will be manufactured, was inaugurated this Thursday at Havana’s Center for Genetic Engineering and Biotechnology (CIGB). President Miguel Díaz-Canel opened the plant.

At the plant, identified with number 14 in the CIGB, the active pharmaceutical ingredient of the drug Jusvinza will be produced, used in the treatment of seriously and critically ill patients with the disease caused by the SARS-CoV-2 coronavirus, said the official Cubadebate website, which quotes the portal of the island’s presidency.

https://twitter.com/PresidenciaCuba/status/1288867927148691456?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1288867927148691456%7Ctwgr%5E&ref_url=https%3A%2F%2Foncubanews.com%2Fcuba%2Fcuba-inaugura-planta-para-producir-medicamento-contra-la-covid-19%2F

The installed capacity for this stage, according to the source, meets the national demand for the drug, formerly known as CIGB-258, and, in addition, can produce other drugs for the treatment of oncological and autoimmune diseases such as rheumatoid arthritis.

In this way, the new facility joins the production complex of one of the main scientific centers in Cuba, and expands its possibilities to produce medicines using chemical synthesis technology at an industrial level, Cubadebate affirmed.

Related Posts

Headquarters of the Matanzas People’s Court, where the trial was held. Photo: Matanzas People’s Court/Facebook.

Prosecutor’s Office requests up to 9 years in prison for synthetic drug trafficking in Matanzas

June 30, 2025
Photo: Kaloian.

Private sector and tourism in Cuba. Why not?

June 26, 2025
Morro Castle

Morro Castle, the light that guards the bay

June 22, 2025
xr:d:DAFlLH53xAU:282,j:1521492641457684093,t:23090415

Government authorizes representation in Cuba of five more foreign companies, one from the U.S.

June 21, 2025

Why has Cuban biotechnology been successful against COVID-19? (I)

The biotechnology industry has vast experience and proven quality in Cuba, which has earned it the recognition of the international scientific community. Its role has been fundamental in confronting COVID-19 on the island, as several of its products, including Jusvinza, recombinant interferon alfa 2b and Itolizumab, have demonstrated their effectiveness as part of the Cuban medical protocol against the disease.

  • OnCuba Staff
    OnCuba Staff,
  • OnCuba editorial staff
Tags: coronavirus in CubaCuban science
Previous Post

Coronavirus in Cuba: more than 3,600 tests, 11 were positive

Next Post

French company interrupts remittance transfers to Cuba and the United States places Cuban bank on blacklist

OnCuba Staff

OnCuba Staff

OnCuba Staff

OnCuba Staff

Next Post
Photo: World Finance.

French company interrupts remittance transfers to Cuba and the United States places Cuban bank on blacklist

Photo: Alejandro Ernesto Pérez Estrada

Eusebio Leal is dead

Yesterday 3,502 tests were made, with which the country has processed a total of 267,649 to date; 2,633 of them have been positive. Photo: Yander Zamora/EFE

Cuba closes July with 25 new COVID-19 cases, one is a foreigner

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

Most Read

  • Flags of Cuba and the United States, seen in perspective in Havana. Photo: Otmaro Rodríguez.

    Trump reinstates hard-line Cuba embargo as Havana condemns US measure as “criminal”

    17 shares
    Share 7 Tweet 4
  • CIA documents revealing attempts to assassinate Fidel and Raúl Castro declassified

    48 shares
    Share 19 Tweet 12
  • The Enchanted Shrimp of the Cuban Dance

    3057 shares
    Share 1223 Tweet 764
  • A sanctuary for jazz in Cuba: César López’s dream

    8 shares
    Share 3 Tweet 2
  • A visit to what we were

    8 shares
    Share 3 Tweet 2

Most Commented

  • Photo: Kaloian.

    Private sector and tourism in Cuba. Why not?

    10 shares
    Share 4 Tweet 3
  • About us
  • Work with OnCuba
  • Terms of use
  • Privacy Policy
  • Moderation policy for comments
  • Contact us
  • Advertisement offers

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

No Result
View All Result
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}